Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerJan B. Vermorken, Ricardo Hitt|New England Journal of Medicine|2008Cited by 3.7k
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckJosé Baselga, A. Eckardt, Ricardo Hitt et al.|Journal of Clinical Oncology|2005Cited by 491
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck CancerRicardo Hitt, H. Cortés-Funes, Joan Carles et al.|Journal of Clinical Oncology|2005Cited by 454
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancerRicardo Hitt, Javier García, Juan J. Grau et al.|Annals of Oncology|2013Cited by 351
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neckRicardo Hitt, Juan Jesús Cruz, Antonio Irigoyen López et al.|Annals of Oncology|2011Cited by 222